腹主动脉瘤腔内治疗术后风险相关的不良形态学特征研究进展  

Research progress on adverse morphologic features associated with postoperative risk of endovascular aortic repair

作　　者：王永刚 史振宇 符伟国 WANG Yong-gang;SHI Zhen-yu;FU Wei-guo(Department of Vascular Surgery,Zhongshan Hospital,Fudan University-Institute of Vascular Surgery,Fudan University-National Clinical Research Center for Interventional Medicine,Shanghai 200032,China)

机构地区：[1]复旦大学附属中山医院血管外科-复旦大学血管外科研究所-国家放射与治疗临床医学研究中心,上海200032

出　　处：《复旦学报（医学版）》2023年第1期154-158,共5页Fudan University Journal of Medical Sciences

基　　金：国家自然科学基金(81870342)。

摘　　要：腹主动脉瘤(abdominal aortic aneurysm,AAA)是最常见的主动脉瘤,占病例的75%,其病情凶险危及生命。腔内治疗(endovascular aortic repair,EVAR)是形态学特征良好的AAA患者的首选治疗方式,随着手术医师经验的积累和产品的更新换代,越来越多的研究报道了EVAR在不良形态学特征AAA患者应用的疗效。近年来,研究者聚焦AAA不良形态学特征与EVAR术后风险之间的关系,目的是为临床医师评估EVAR风险提供依据。本文将对不良形态学特征在EVAR术后相关死亡、移植物相关并发症和EVAR术后再干预的研究进展进行综述。Abdominal aortic aneurysm(AAA) as the most common aortic aneurysm, comprising 75%of cases,is a critical condition disease that can be life-threatening. Endovascular aortic repair(EVAR) has now become the mainstream treatment for patients with suitable morphologic features. With the improved surgeon experience and stent grafts products update, more and more studies have reported the efficacy of EVAR for AAA patients with adverse morphologic features. In recent years, investigators have focused on the relationship between adverse morphologic features and the outcome after EVAR, with the aim of providing a basis for clinicians to assess the risk of EVAR. In this review, the research progress of adverse morphologic features in EVAR related mortality, stent-graft related complications and reintervention after EVAR is reviewed.

关 键 词：腹主动脉瘤 腔内治疗 形态学特征 风险因素 

分 类 号：R543.16[医药卫生—心血管疾病]